Fluvoxamine is a potent inhibitor of cytochrome P4501A2
- 24 March 1993
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (6), 1211-1214
- https://doi.org/10.1016/0006-2952(93)90272-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Inhibitors of imipramine metabolism by human liver microsomes.British Journal of Clinical Pharmacology, 1992
- Interaction Between Fluvoxamine and Imipramine/Desipramine in Four PatientsTherapeutic Drug Monitoring, 1992
- Uroporphyrinogen oxidation catalyzed by reconstituted cytochrome P450IA2Archives of Biochemistry and Biophysics, 1992
- Characterization of metronidazole metabolism by human liver microsomesBiochemical Pharmacology, 1991
- The P450 Superfamily: Update on New Sequences, Gene Mapping, and Recommended NomenclatureDNA and Cell Biology, 1991
- Toxic Interaction Between Fluvoxamine and Sustained Release Theophylline in an 11-Year-Old BoyDrug Safety, 1991
- A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O‐deethylation of phenacetin and is inducible by cigarette smoking.British Journal of Clinical Pharmacology, 1988
- PhenacetinO-deethylation by human liver microsomes: Kinetics and propranolol inhibitionXenobiotica, 1988
- FluvoxamineDrugs, 1986
- Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractionsBiochemical Pharmacology, 1981